Navigation Links
Global Orphan Drug Market Future Outlook 2015-2020
Date:6/8/2015

DUBLIN, June 08, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/g8q842/global_orphan) has announced the addition of the "Global Orphan Drug Market Future Outlook 2020" report to their offering.

In recent years, several new rare diseases are being included in clinical trials for the development of orphan drug candidate. Oncology, Genetic diseases, Autoimmune, pulmonary disease, Central nervous system and others are main focus of orphan drug developers. All of these diseases have large patient base but their rare forms doesn't have suitable therapeutics which reflects the marketing potential of orphan drugs in these segments.

Out of these, oncology segment has got maximum attention followed by rare genetic disorders, neurological disorder and autoimmune disorders. In a bigger view, orphan drug segment is expected to grow several folds in coming years due to several favorable factors. Introduction of innovative technologies, favorable pricing, reimbursement, unmet medical necessities and strong clinical pipeline could be attributed as important factors responsible for their growth.

"Global Orphan Drug Market Future Outlook 2020" report highlights:

- Global Orphan Drug Market Overview
- Global Orphan Drug Market Segment Analysis
- FDA & EMA Regulation for Clinical Trials Orphan Designated Drugs
- Orphan Drug Designation Criteria & Reimbursement Policy by Region
- Comprehensive Insight on Global Orphan Drugs Clinical Pipeline & Patent Analysis by Company, Country, Indication & Phase
- Global Orphan Drugs Clinical Pipeline: 697 Drugs
- Majority Orphan Drugs in Phase-II Trials: 249 Drugs
- Marketed Orphan Drugs: 274 Drugs

Key Topics Covered:

1. Introduction to Orphan Drug

2. Favorable Market Dynamics for Orphan Drugs Commercialization

3. Global Orphan Drug Market Overview

4. Global Orphan Drug Market Segment Analysis

5. Global Orphan Drug Clinical Pipeline Overview

6. US Orphan Drug Market Overview

7. Europe Orphan Drug Market Overview

8. Asia Orphan Drug Market Overview

9. FDA Regulation for Clinical Trials Orphan Designated Drugs

10. EMA Regulations for Clinical Trials of Orphan Designated Drugs

11. Asian Regulations for Clinical Trials of Orphan Designated Drugs

12. Global Orphan Drugs Clinical Pipeline Insight & Patent Analysis by Company, Country, Indication & Phase

13. Marketed Orphan Drugs Clinical Insight & Patent Analysis by Company, Country & Indication

14. Discontinued & Suspended Orphan Drugs in Clinical Trials

15. Competitive Landscape

- AOP Orphan
- Agenus
- Alexion
- Biogen Idec
- Bristol Myers Squibb
- Celgene
- Eli Lilly
- Genethon
- Genzyme Corporation
- Glaxosmithkline
- Merck
- Novartis Pharmaceuticals
- Orphan Europe
- Pfizer
- Prosensa
- Rare Disease Therapeutics
- Roche
- Sanofi
- Shire
- Teva Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/g8q842/global_orphan

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Streptavidin (CAS 9013-20-1): Market Research Report 2015
2. AbbVie to Present at Goldman Sachs 36th Annual Global Healthcare Conference
3. Global Healthcare Financial Analytics Market 2015 - Growth, Trends & Forecast To 2020
4. Quest Diagnostics to Speak at the Goldman Sachs 36th Annual Global Healthcare Conference
5. Isis Pharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
6. Global Halogen Surgical Light Industry Report 2015
7. Global Electric Surgical Liposuction Pump Industry Report 2015
8. Global Surgical Incision Closures Industry
9. Global Blood Processing Supplies and Equipment Industry
10. Elastomers: Applications and Global Markets
11. Global Laboratory Centrifuges Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... September 14, 2018 , ... Today, ... showcases the innovative work being done within rare diseases research diagnostics and highlights ... with rare diseases. , The print component of "Rare Diseases" ...
(Date:9/15/2018)... CEDAR POINT, N.C. (PRWEB) , ... September 14, 2018 , ... ... is now on the map thanks to Hurricane Florence. I am planning this Women ... it while living out of a suitcase and knowing I have to hold onto ...
(Date:9/13/2018)... ... September 13, 2018 , ... The ultimate fitness experience has hit Astoria. A ... new arrival is called Form50 Fitness . , The studio practices the Lagree ... - a hybrid Pilates reformer with pulleys, weights, grasps and glides. The method and ...
Breaking Medicine Technology:
(Date:9/22/2018)... ... 2018 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... event held each year during Blood Cancer Awareness Month. , This year’s event ...
(Date:9/15/2018)... ... September 14, 2018 , ... Today, Mediaplanet announces the ... innovative work being done within rare diseases research, diagnostics, and will highlight what ... rare diseases. , Clay Matthews, Super Bowl-winning linebacker for the ...
(Date:9/13/2018)... , ... September 13, 2018 , ... ... honoring National Gum Care Month to educate their patients and the general public ... advanced equipment and procedures. Not only do Drs. Nash have extensive training in ...
(Date:9/13/2018)... ... , ... Pulsara is honored to be represented by its CEO, Dr. James ... in Chicago. Dr. Woodson, ER Physician and Founder/CEO of Pulsara, has been invited ... Communication & Collaboration (CC&C) is Not Enough: Why You Need a Regional Communication Network.” ...
(Date:9/12/2018)... ... September 12, 2018 , ... Today, Sterling , ... Maureen Beck, attempted the first unassisted adaptive climb of the Lotus Flower Tower in ... made it difficult for him to lead, the duo decided to persevere and with ...
Breaking Medicine News(10 mins):